You can:
Name | Vasoactive intestinal polypeptide receptor 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | VIPR1 |
Synonym | VPAC1 VIP-R-1 VIP and PACAP receptor 1 VIP-R1 RDC1 [ Show all ] |
Disease | Respiratory disease Chronic obstructive pulmonary disease; Pulmonary arterial hypertension |
Length | 457 |
Amino acid sequence | MRPPSPLPARWLCVLAGALAWALGPAGGQAARLQEECDYVQMIEVQHKQCLEEAQLENETIGCSKMWDNLTCWPATPRGQVVVLACPLIFKLFSSIQGRNVSRSCTDEGWTHLEPGPYPIACGLDDKAASLDEQQTMFYGSVKTGYTIGYGLSLATLLVATAILSLFRKLHCTRNYIHMHLFISFILRAAAVFIKDLALFDSGESDQCSEGSVGCKAAMVFFQYCVMANFFWLLVEGLYLYTLLAVSFFSERKYFWGYILIGWGVPSTFTMVWTIARIHFEDYGCWDTINSSLWWIIKGPILTSILVNFILFICIIRILLQKLRPPDIRKSDSSPYSRLARSTLLLIPLFGVHYIMFAFFPDNFKPEVKMVFELVVGSFQGFVVAILYCFLNGEVQAELRRKWRRWHLQGVLGWNPKYRHPSGGSNGATCSTQVSMLTRVSPGARRSSSFQAEVSLV |
UniProt | P32241 |
Protein Data Bank | N/A |
GPCR-HGmod model | P32241 |
3D structure model | This predicted structure model is from GPCR-EXP P32241. |
BioLiP | N/A |
Therapeutic Target Database | T86364 |
ChEMBL | CHEMBL5144 |
IUPHAR | 371 |
DrugBank | N/A |
Name | NSC157267 |
---|---|
Molecular formula | C13H16ClNO2 |
IUPAC name | (E)-3-(4-chlorophenyl)-N-(1-hydroxybutan-2-yl)prop-2-enamide |
Molecular weight | 253.726 |
Hydrogen bond acceptor | 2 |
Hydrogen bond donor | 2 |
XlogP | 2.3 |
Synonyms | (E)-3-(4-chlorophenyl)-N-(1-hydroxybutan-2-yl)prop-2-enamide AC1O3OFM CHEMBL3884786 AKOS005832485 NSC-157267 |
Inchi Key | PRRQIMZFWXXIRY-VMPITWQZSA-N |
Inchi ID | InChI=1S/C13H16ClNO2/c1-2-12(9-16)15-13(17)8-5-10-3-6-11(14)7-4-10/h3-8,12,16H,2,9H2,1H3,(H,15,17)/b8-5+ |
PubChem CID | 6310476 |
ChEMBL | CHEMBL3884786 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Inhibition | 4.8 % | PMID27876250 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417